Accomplishments in Cancer ResearchLippincott, 1984 - Awards |
From inside the book
Results 1-3 of 6
Page 140
... Aminoglutethimide Initially developed for use as an anticonvulsant , aminoglutethimide , an analogue of glutethimide ( a hypnotic ) ( Fig . 6 ) , was withdrawn because of its suppressing effect on the function of the adrenal and thyroid ...
... Aminoglutethimide Initially developed for use as an anticonvulsant , aminoglutethimide , an analogue of glutethimide ( a hypnotic ) ( Fig . 6 ) , was withdrawn because of its suppressing effect on the function of the adrenal and thyroid ...
Page 141
... aminoglutethimide may induce a further response after initial tamoxifen therapy has failed.49.50 51 Although side effects ( gastrointestinal disturbance , lethargy and al- lergic manifestations ) can be troublesome , a trial of ...
... aminoglutethimide may induce a further response after initial tamoxifen therapy has failed.49.50 51 Although side effects ( gastrointestinal disturbance , lethargy and al- lergic manifestations ) can be troublesome , a trial of ...
Page 169
... Aminoglutethimide can have quite troublesome side effects particularly skin rash . It is for this reason that there is interest in administering smaller doses and a recent report indicates that a dose of 500 mg ( rather than 1 g ) still ...
... Aminoglutethimide can have quite troublesome side effects particularly skin rash . It is for this reason that there is interest in administering smaller doses and a recent report indicates that a dose of 500 mg ( rather than 1 g ) still ...
Contents
Views of Cancer Research | 1 |
Overview of the Prizes | 5 |
Selecting the 1984 Prizewinners | 13 |
Copyright | |
28 other sections not shown
Other editions - View all
Common terms and phrases
Acad Sci USA activity aflatoxin aminoglutethimide animals antigens assays Awards Assembly Barnett Rosenberg breast cancer cancer cells Cancer Res Cancer Research carriers cell lines chemotherapy chromosomes cisplatin clinical cloned culture cytotoxicity differentiation disease dose drug effect embryonal carcinoma endometrial estrogen evidence Fortner G-CSF Gallo RC genetic genome growth factor HBsAg Hellström hemopoietic hepatitis B virus hepatocellular carcinoma hepatocytes hormone HTLV HTLV-I human breast cancer human T-cell immune infection IORT Kettering Prize Lancet leukemia cells leukemic levels liver cancer lymphoma malignant melanoma melanoma cells mice molecular molecules monoclonal antibodies mouse myeloid leukemia Natl Acad Sci Natl Cancer Inst normal onc genes oncogenes oral contraceptives pancreas patients plasma platinum primary Prize Proc Natl Acad prolactin proliferation protein radiation therapy receptor retroviruses sarcoma serum specific src gene stimulation synthesis T-cell leukemia tamoxifen tissues treatment tumor cells vaccine Varmus viral viruses vitro vivo York